Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Applied Molecular Transport

    Client Virtual Booth

    APPLIED MOLECULAR TRANSPORT

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Applied Molecular Transport
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Tower Place Suite 850 South San Francisco, CA 94080
    Telephone
    Telephone
    +1 650.392.0420
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.appliedmt.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
    Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.

    https://www.businesswire.com/news/home/20231227151063/en

    BUSINESSWIRE
    27 Dec 2023
    Share Share
    Applied Molecular Transport Reports Third Quarter 2023 Financial Results
    Applied Molecular Transport Reports Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/09/2777778/0/en/Applied-Molecular-Transport-Reports-Third-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    09 Nov 2023
    Share Share
    Cyclo and Applied Molecular Transport Enter into a Definitive Merger Agreement
    Cyclo and Applied Molecular Transport Enter into a Definitive Merger Agreement

    https://www.businesswire.com/news/home/20230921110888/en

    BUSINESSWIRE
    21 Sep 2023
    Share Share
    Applied Molecular Transport Reports Second Quarter 2023 Financial Results
    Applied Molecular Transport Reports Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/14/2724950/0/en/Applied-Molecular-Transport-Reports-Second-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    14 Aug 2023
    Share Share
    Applied Molecular Transport Reports First Quarter 2023 Financial Results
    Applied Molecular Transport Reports First Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/05/11/2667310/0/en/Applied-Molecular-Transport-Reports-First-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    11 May 2023
    Share Share
    AMT lays off further 57% of staff, seeks strategic alternatives
    AMT lays off further 57% of staff, seeks strategic alternatives

    https://www.fiercebiotech.com/biotech/amt-lays-further-57-employees-seeks-out-strategic-alternatives

    James Waldron FIERCE BIOTECH
    28 Mar 2023
    Share Share
    Applied Molecular Transport Announces Corporate Leadership Change
    Applied Molecular Transport Announces Corporate Leadership Change

    https://www.globenewswire.com/news-release/2023/03/27/2635214/0/en/Applied-Molecular-Transport-Announces-Corporate-Leadership-Change-and-Process-to-Explore-Strategic-Alternatives.html

    GLOBENEWSWIRE
    27 Mar 2023
    Share Share
    After slimming R&D, AMT no closer to taking UC drug into phase 3
    After slimming R&D, AMT no closer to taking UC drug into phase 3

    https://www.fiercebiotech.com/biotech/after-slimming-down-applied-molecular-transport-no-closer-taking-uc-drug-phase-3

    James Waldron FIERCE BIOTECH
    10 Mar 2023
    Share Share
    Applied Molecular Reports Fourth Quarter and Full Year 2022 Financial Results
    Applied Molecular Reports Fourth Quarter and Full Year 2022 Financial Results

    https://www.globenewswire.com/news-release/2023/03/09/2624578/0/en/Applied-Molecular-Transport-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    09 Mar 2023
    Share Share
    Applied Molecular Presents Data from Oral AMT-101 Phase 2 FILLMORE Trial
    Applied Molecular Presents Data from Oral AMT-101 Phase 2 FILLMORE Trial

    https://www.globenewswire.com/news-release/2023/03/03/2620197/0/en/Applied-Molecular-Transport-Presents-Additional-Data-from-Oral-AMT-101-Phase-2-FILLMORE-Trial-in-Chronic-Pouchitis-at-ECCO-23-Congress.html

    GLOBENEWSWIRE
    03 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search